SDC1 and systemic lupus erythematosus: It is important to note that our SLE cohort is of relatively low disease activity which might explain why we do not see increased frequencies of CD138+ cells in the periphery as has been recently reported by other groups utilizing SLE patients with higher SLEDAI (41).